Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Recruiting
Observational Study
Metabolic Syndrome (MetS)
Obesity & Overweight
Cardiovascular Diseases (CVD)
Chronic Kidney Disease
Nonalcoholic Fatty Liver Disease
Healthy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,266 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and trea…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals (male or female) aged 20 years or older
* Willing and able to provide written informed consent to participate in the study
Exclusion Criteria:
* Pregnant or breastfeeding women
* Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
…
Contacts